HomeComparePTLKF vs PFE

PTLKF vs PFE: Dividend Comparison 2026

PTLKF yields 400000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTLKF wins by $5.011119029548644e+32M in total portfolio value
10 years
PTLKF
PTLKF
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full PTLKF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PTLKF vs PFE

📍 PTLKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTLKFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTLKF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTLKF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTLKF
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PTLKF beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTLKF + PFE for your $10,000?

PTLKF: 50%PFE: 50%
100% PFE50/50100% PTLKF
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PTLKF
No analyst data
Altman Z
1.1
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTLKF buys
0
PFE buys
0
No recent congressional trades found for PTLKF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTLKFPFE
Forward yield400000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$5.011119029548644e+32M$49.6K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$26,258.71
Total dividends collected$5.010957816668433e+32M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTLKF vs PFE ($10,000, DRIP)

YearPTLKF PortfolioPTLKF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$40,010,700$40,000,000.00$9,153$693.39+$40.00MPTLKF
2$149,615,521,729$149,572,710,280.37$8,593$849.25+$149615.51MPTLKF
3$522,880,052,725,200$522,719,964,116,949.25$8,336$1,066.78+$522880052.72MPTLKF
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$8,437$1,384.80+$1707862989289.04MPTLKF
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$9,013$1,875.40+$5213509402845684.00MPTLKF
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$10,306$2,680.72+$14874219058409543680.00MPTLKF
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$12,820$4,101.38+$3.966119623405075e+22MPTLKF
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$17,673$6,826.70+$9.88384363503273e+25MPTLKF
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$27,543$12,591.86+$2.302052364743449e+29MPTLKF
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$49,560$26,258.71+$5.011119029548644e+32MPTLKF

PTLKF vs PFE: Complete Analysis 2026

PTLKFStock

PT Lippo Karawaci Tbk, together with its subsidiaries, provides property development services in Indonesia. It operates in three segments: Real Estate Development, Real Estate Management & Services, and Fund Management/Investments. The Real Estate Development segment is involved in the real estate activities, including urban development; development of facilities and its infrastructure; large scale integrated and infrastructure development projects, such as residential condominiums, commercial and entertainment areas, office space, and healthcare and education facilities; food business; and other investments. The Real Estate Management & Services segment develops and manages shopping center; operates hotels, recreation centers, and restaurants; provides health, town management, and water and sewage treatment services; and offers transportation and maintenance services. The Fund Management/Investments segment provides management services. The company provides financial, professional, scientific, and technical services; construction, transportation, trading, water management and treatment, wastewater management, waste management and recycling, parking, remediation, employment, and other supporting services, as well as hospital, clinic, health center, polyclinic, and other related services. In addition, it engages in investment, development, printing, agriculture, gardening, workshop, pharmaceutical wholesale, mining, computer programming, other management consulting, hotel management, township development, asset management, home care, and air installation activities. As of December 31, 2021, it operated 40 hospitals; 59 malls, including 49 leased and 10 strata-titled malls; and 10 hotels. The company was formerly known as PT Tunggal Reksakencana. PT Lippo Karawaci Tbk was founded in 1990 and is headquartered in Tangerang, Indonesia.

Full PTLKF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PTLKF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTLKF vs SCHDPTLKF vs JEPIPTLKF vs OPTLKF vs KOPTLKF vs MAINPTLKF vs JNJPTLKF vs MRKPTLKF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.